Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Non Operating Income: 2023-2024

Historic Non Operating Income for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $26.6 million.

  • CG Oncology's Non Operating Income fell 7.21% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 23.57%. This contributed to the annual value of $26.6 million for FY2024, which is 289.17% up from last year.
  • Per CG Oncology's latest filing, its Non Operating Income stood at $26.6 million for FY2024, which was up 289.17% from $6.8 million recorded in FY2023.
  • CG Oncology's 5-year Non Operating Income high stood at $26.6 million for FY2024, and its period low was $6.8 million during FY2023.
  • Moreover, its 2-year median value for Non Operating Income was $16.7 million (2023), whereas its average is $16.7 million.
  • Data for CG Oncology's Non Operating Income shows a peak YoY soared of 289.17% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Non Operating Income stood at $6.8 million in 2023, then soared by 289.17% to $26.6 million in 2024.